These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 362913)
21. [Choice of digitalis glycosides]. Clément D Ther Umsch; 1970 Mar; 27(3):181-4. PubMed ID: 5437616 [No Abstract] [Full Text] [Related]
22. [Formulas for the simplified calculation of the effective level of glycosides in heart therapy]. Mitzkat HJ; Bronsert U Int J Clin Pharmacol; 1972 Apr; 6(1):88-91. PubMed ID: 5048675 [No Abstract] [Full Text] [Related]
23. The absorption, distribution and excretion of K-strophanthoside-3H in guinea pigs after parenteral administration. Marzo A; Ghirardi P; Marchetti G J Pharmacol Exp Ther; 1974 Apr; 189(1):185-93. PubMed ID: 4823291 [No Abstract] [Full Text] [Related]
24. [Pharmacology of cardiotonic glycosides]. Berdeaux A Rev Prat; 1986 Oct; 36(43):2499-505. PubMed ID: 3787145 [No Abstract] [Full Text] [Related]
26. [Pharmacology and therapeutic effects of a new semisynthetic cardioactive glycoside (P1)]. Königstein RP; Lindner A; Selzer H Wien Med Wochenschr; 1971 Jan; 121(4):53-6. PubMed ID: 5103273 [No Abstract] [Full Text] [Related]
27. [Clinical study of meproscillarin rates of inactivation and persistence, bioavailability and maintenance dose]. Herken H; Brandes J Arzneimittelforschung; 1978; 28(3a):557-60. PubMed ID: 580590 [TBL] [Abstract][Full Text] [Related]
28. [Metabolism and intestinal absorption of cardiac glycosides]. Lauterbach F Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199 [No Abstract] [Full Text] [Related]
29. Principles of drug therapy in patients with renal disease. Bennett WM West J Med; 1975 Nov; 123(5):372-9. PubMed ID: 1210331 [TBL] [Abstract][Full Text] [Related]
30. [Quantitative studies on the therapeutic range of cardiac glycosides]. Diederen W; Kadatz R Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016 [No Abstract] [Full Text] [Related]
31. [Drug interaction with cardiac glycosides (a review of the literature)]. Chekman IS; Viktorov AP; Angelutsa PA; Grinevich AI; Roshchupkina EV Vrach Delo; 1990 Jul; (7):32-7. PubMed ID: 2238591 [No Abstract] [Full Text] [Related]
32. [Optimization of therapy using cardiac glycosides]. Ziesenhenn K; Behn P Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673 [TBL] [Abstract][Full Text] [Related]
34. [Cardiac glycosides--structure, preparation and therapeutic use]. Luckner M; Diettrich B Pharmazie; 1979 Aug; 34(8):477-81. PubMed ID: 538073 [No Abstract] [Full Text] [Related]
35. [The important aim and route of studies on cardiac glycosides (author's transl)]. Lu FH Yao Xue Xue Bao; 1979; 14(10):632-40. PubMed ID: 539432 [No Abstract] [Full Text] [Related]
36. [Pharmacodynamics, pharmacokinetics and side effects of cardiac glycosides]. Sivkov II; Kukes VG; Ibadova DN; Shokhor VIa; Otdelenov AV Vestn Akad Med Nauk SSSR; 1987; (9):83-7. PubMed ID: 3673236 [No Abstract] [Full Text] [Related]
37. [Biochemical aspects of the therapeutic use of cardiac glycosides]. Savitskiĭ NN Ter Arkh; 1972 Jan; 44(1):5-11. PubMed ID: 5017540 [No Abstract] [Full Text] [Related]
38. [Cardioactive therapy in the elderly]. Macchione C G Gerontol; 1972 May; 20(5):434-42. PubMed ID: 5052155 [No Abstract] [Full Text] [Related]
39. [The current concepts of the effect of cardiac glycosides on sinus node function and atrioventricular conductivity]. Bobrov VA; Shchepotin IuB Ter Arkh; 1991; 63(9):142-4. PubMed ID: 1759209 [TBL] [Abstract][Full Text] [Related]